Nippon Steel Corporation (NPSCY)

Ligand Pharmaceuticals Revenue

Nippon Steel had revenue of 2.01T JPY in the quarter ending June 30, 2025, a decrease of -8.34%. This brings the company's revenue in the last twelve months to 8.51T, down -3.92% year-over-year. In the fiscal year ending March 31, 2025, Nippon Steel had annual revenue of 8.70T, down -1.95%.

• Revenue (ttm): 8,512.77B JPY
• Revenue Growth: -3.92%
• P/S Ratio: 0.36
• Revenue / Employee: 74.78M JPY
• Employees: 113,845
• Market Cap: 21.17B USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	8,695.53B	-172.57B	-1.95%
Mar 31, 2024	8,868.10B	892.51B	11.19%
Mar 31, 2023	7,975.59B	1,166.70B	17.13%
Mar 31, 2022	6,808.89B	1,979.62B	40.99%
Mar 31, 2021	4,829.27B	-1,092.25B	-18.45%